Kilitch Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 March 2026.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales53.8156.17 -4 OPM %11.4315.54 - PBDT6.539.06 -28 PBT5.608.25 -32 NP4.435.96 -26 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) declined 4.99% to Rs 8.19 crore in the quarter ended September 2025 as against Rs 8.62 crore during the previous quarter ended September 2024. Sales rose 3.05% to Rs 48.92 crore in the quarter ended September 2025 as against Rs 47.47 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales48.9247.47 3 OPM %10.3012.85 - PBDT10.2610.95 -6 PBT9.4010.35 -9 NP8.198.62 -5 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News